RNAi-mediated EZH2 depletion decreases MDR1 expression and sensitizes multidrug-resistant hepatocellular carcinoma cells to chemotherapy

By            

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1037-1042

Spandidos Publications

Access to resources Recommend Favorite

Antitumor effect and mechanism of an ellagic acid derivative on the HepG2 human hepatocellular carcinoma cell line

By              

Oncology Letters, Vol. 7, Iss. 2, 2014-01 ,pp. : 525-530

Spandidos Publications

Access to resources Recommend Favorite

Expression and roles of fatty acid synthase in hepatocellular carcinoma

By  

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2471-2476

Spandidos Publications

Access to resources Recommend Favorite

Styrene Maleic Acid Neocarzinostatin Treatment for Hepatocellular Carcinoma

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 6, 2002-11 ,pp. : 715-726

Bentham Science Publishers

Access to resources Recommend Favorite

A decade’s studies on metastasis of hepatocellular carcinoma

By Tang Zhao-You   Ye Sheng-Long   Liu Yin-Kun   Qin Lun-Xiu   Sun Hui-Chuan   Ye Qin-Hai   Wang Lu   Zhou Jian   Qiu Shuang-Jian   Li Yan   Ji Xue-Ning   Liu Hu   Xia Jing-Ling   Wu Zhi-Quan   Fan Jia   Ma Zeng-Chen   Zhou Xin-Da   Lin Zhi-Ying   Liu Kang-Da  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 4, 2004-04 ,pp. : 187-196

Springer Publishing Company

Access to resources Recommend Favorite